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Abstract: Dysbiosis refers to a reduction in microbial diversity, combined with a loss of beneficial
taxa, and an increase in pathogenic microorganisms. Dysbiosis of the intestinal microbiota can have
a substantial effect on the nervous and immune systems, contributing to the onset of several inflammatory diseases. Epidemiological studies provided insight in how changes in the living environment
have contributed to an overall loss of diversity and key taxa in the gut microbiome, coinciding
with increased reports of atopy and allergic diseases. The gut microbiome begins development at
birth, with major transition periods occurring around the commencement of breastfeeding, and
the introduction of solid foods. As such, the development of the gut microbiome remains highly
plastic and easily influenced by environmental factors until around three years of age. Developing
a diverse and rich gut microbiome during this sensitive period is crucial to setting up a stable gut
microbiome into adulthood and to prevent gut dysbiosis. Currently, the delivery route, antibiotic
exposure, and diet are the best studied drivers of gut microbiome development, as well as risk factors
of gut dysbiosis during infancy. This review focuses on recent evidence regarding key environmental
factors that contribute to promoting gut dysbiosis.
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1. Introduction
The gastrointestinal tract (GIT) is inhabited by a diverse and densely populated
collection of microorganisms known as the gut microbiome, most of which are obligate
anaerobes, and the majority of which belong to a small number of phyla, particularly
firmicutes, bacteroidetes, and actinobacteria [1]. The gut microbiome is the most diverse
and species rich of all microbiome niches in the human body. Humans and the bacteria that
inhabit their GITs have coevolved to exist with a mutually beneficial symbiotic relationship.
Whilst the human body acts as a well-adapted living environment, the gut microbiota
provide physiological benefits to the host [2]. For example, fermentation of indigestible
carbohydrates producing short chain fatty acids (SCFAs) that influence the development
and function of the immune and nervous systems [3]. As well as its involvement in host
health, study of the gut microbiome has been of increasing importance due to its dynamic
nature; a growing body of evidence suggests it has a vital role in disease progression and
prevention [4,5].
Host benefits of the gut microbiome are apparent when there is homeostasis in the relationship between the host and the gut microbiome. However, this is not always observed
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and a dysbiotic relationship often develops. Broadly defined, dysbiosis refers to an “imbalance” in a microbial community. This can result from a gain or loss of some of the microbial
community members. This imbalance may be the result of a loss of overall diversity, a
loss in beneficial microorganisms, or a gain of pathogenic species, often associated with a
pathological state. Growing evidence suggests that gut dysbiosis is associated with several
non-communicable diseases (for example, intestinal diseases include coeliac disease, inflammatory bowel disease, and irritable bowel syndrome, or systemic disorders such as
asthma, allergy, and obesity). These diseases are increasing in prevalence in many regions
of the world [6–8] and, as an example, thirty to forty percent of the world’s population is
now affected by one or more allergic diseases [9,10], while only a few percent were affected
a few decades ago. Such a high prevalence of non-communicable diseases has been linked
to environmental and socioeconomic factors associated with modernisation [11]. Epidemiological studies have found a loss of overall diversity and key taxa in the gut microbiome
is associated with changes in the living environment, diet and lifestyles [12]. Over the
past few decades, several aspects of the human condition and environment have shifted
dramatically, which has repeatedly coincided with a sustained increase in the incidence of
allergies in early childhood. Specifically, factors known to influence the gut microbiome
associated with modern lifestyles include sanitary improvements, increased rates of caesarean sections, smaller family sizes, sedentary lifestyles, increased usage of antibiotics,
decreased Helicobacter pylori infections, and poorer diets [13]. While gut dysbiosis can occur
at any point during life’s course, recent research has linked early gut dysbiosis with later
onset of disease, highlighting the need to better understand the origins of gut dysbiosis.
It remains important to understand the complex interplay between host genetics, GIT
development, and environmental factors that lead to gut dysbiosis as a key preventative
strategy against rising rates of non-communicable diseases. Developmental plasticity of
the gut microbiome is highest in the first few years of life and evidence suggests this is a
period of heightened susceptibility to dysbiosis [14].
With the advent of metagenomic sequencing the role of the gut microbiome in regulating human physiology, digestion, detoxification, and nervous and immune system
development has been an increasing area of interest. Humans are now considered to have
two separate genomes, one which is inherited, and the other (the microbial), which is
acquired. The microbial genome has been noted to have far more genes (33 million) than
the host genome (27 thousand). While the inherited genome is stable during the course of
life, the microbial genome is dynamic and can be altered by a variety of factors, particularly
during infancy. It is therefore important to understand the early life factors that influence
the spatio-temporal acquisition of the microbiota for optimal health and disease prevention.
This review provides an overview of the most pertinent factors relevant to pediatric health
and development.
2. Factors That Shape Development of the Gut Microbiome in Infancy and
Early Childhood
2.1. Parturition
Gut microbiome colonisation is highly variable in early infancy, and only a small
subset of species that reach the GIT manage to colonise [15]. There is some controversy
around when initial seeding of the gut microbiome occurs. However, evidence suggests
initial colonisation of the GIT may begin as early as in utero [16] from species detected
in the infant gut during the second trimester [17], with the mature, stable form of the gut
microbiome being established at around three years of age [18]. Until recently, it was widely
accepted that the foetus developed in a sterile environment and intestinal colonisation did
not begin until birth (when the infant is first exposed to the mother’s vaginal and faecal
microorganisms). However, recent studies have now identified microorganisms in the
placenta [19], amniotic fluid [20], umbilical cord [21], and meconium [22]. Despite these
observations, there is an ongoing debate that these published studies did not adequately
control for contamination. However, the mounting evidence means it has now become gen-
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2.2. Early Postnatal Life
A longitudinal study by Yassour et al., performed on 39 Finnish children aged 2 to
36 months of age collected monthly stool samples to provide insights into the development
of the early infant gut microbiome [32]. They found that an overwhelming majority of
infants in their study had significant levels (average abundances) of Enterobacteriaceae
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(25%), Bifidobacteriaceae (15%), and Clostridiaceae (8%) families, which decreased to a
relative average abundance of 1%, 3%, and 2.5% by 18 months of age [32]. Once solid
food is introduced, the gut microbiome shifts to a majority abundance of species from the
Bacteroides genus, which is essential for starch digestion for a more complex diet [33]. Large
population studies have mostly focused on gut microbiome research in children under
3 years of age, and adults aged 18 to 65 years of age. Thus, there is limited knowledge
spanning the kindergarten and pre-school ages [34]. One study by Zhong et al. on 281 early
school-aged children found that children dominated by Bifidobacterium had lower overall
diversities and bacteria gene counts compared to children dominated by Bacteroides, or
Prevotella [35]. The high levels of Bifidobacterium in school-age children’s gut microbiomes resembles that of an adult. Interestingly, they also found that the Bifidobacterium
dominated group had an overall shorter breast-feeding duration [35]. A systemic review
by Deering et al. has been conducted to address the gap in the literature of school-aged
children’s gut microbiomes. They found the preadolescent gut is dominated by Firmicutes
and Bacteroidetes [36].
2.3. Genetics
Recent studies have found that host genetics can influence the composition of the
human gut microbiome which, in turn, can impact host metabolism. Development of the
neonatal gut microbiome after birth is associated with interactions between the microbiota
and the host immune system. Several studies, including genome-wide association studies,
have found genome-wide significant associations for overall microbial variation [37–39].
A recent study by Xu et al. analysed single-nucleotide polymorphism (SNP) heritability
of 1475 Chinese participants. They found that Desulfovibrionaceae and Odoribacter had
significant heritability estimates of 0.456, and 0.476, respectively [40], which is consistent
with previous research [41]. Genetic variation between individuals can drive variation
in microbiome composition, and twin studies allow us to understand to what extent this
variation is genes or environment driven. One study by Goodrich et al. assessed the
heritability of the gut microbiome using a twin study and noted that monozygotic twins
have more similarities in gut microbiota than dizygotic twins with operational taxonomic
unit (OTU) heritability estimates ranging from 0.2 to 0.4 [42]. OTUs are clusters of similar
sequence variants used to classify closely related species. They also found that there
are many microbial taxa whose abundances were influenced by host genetics, the most
heritable belonging to the Christensenellaceae family [42].
Since large-scale studies have been conducted, the gut microbiome has been revealed
to be highly personalised, even among healthy individuals [43]. It is well-known that
genetic variation exists between human populations and across geographic locations. Gut
bacterial communities have also been shown to vary across human populations [15]. A
recent study by Deschasaux et al. used 16S sequencing to analyse stool samples from over
two thousand adults from the six largest ethnic groups in Amsterdam. They concluded that
ethnic differences from ethnic groups residing in the same geographic location accounted
for a larger proportion of the variation of gut microbiome than other major influencing
factors, including diet [44]. These findings suggest that host-intrinsic genetic diversity
influences gastrointestinal colonisation patterns, as well as environmental factors and
dietary patterns. Deschasaux et al. noted that despite differences in gut microbiome composition between ethnic groups, there were 21 microbial taxa that were ubiquitous among
all 2084 participants across the different ethnic groups [44], suggesting individuals from
the same ethnic group tend to have more similarities in gut microbiome composition than
individuals from different ethnicities [45]. This supports the notion that despite high levels
of inter-individual variation in gut microbiome profiles, there are some ubiquitous species
amongst populations that are important for human health and therefore common across
different population. Understanding the factors that impact gut microbiome development
and composition, including genetics, is critical to recognize the role of the gut microbiome
in disease progression.
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2.4. Infant Feeding
Infant feeding of breast or formula milk has significant influence on the composition
of the early gut microbiota in the first year of life [46]. Extensive research has shown the
short-term and long-term benefits of breast-feeding. Breast milk contains IgA and IgG
immunoglobulins, antimicrobial compounds, lymphocytes, growth factors, vitamins, and
cytokines, which are transferred to the infant and expected to aid the development of a
healthy immune system and to influence shaping of the gut microbiome [47,48]. Breastfed infants tend to have a gut microbiome enriched with Lactobacillus, Staphylococcus,
and Bifidobacterium, compared with formula-fed infants with microbiomes enriched with
Roseburia, Clostridium, and Anaerostipes [25]. Breast-fed infants tend to have less diverse
gut microbiomes but higher levels of Bifidobacterium species, including Bifidobacterium
breve, Bifidobacterum bifidum, and Bifidobacterium longum, which thrive on human milk
oligosaccharides (HMOs) and are highly specialised at digesting HMO’s in breast-milk [49].
HMOs vary from mother to mother based on genetic factors. The majority of mothers
secrete oligosaccharides into their breast milk which is based on the presence of the FUT2
gene, located on chromosome 19 [50]. Some mothers have a benign mutation of this gene,
making them non-secretors, and reducing the diversity of Bifidobacterium in their breastfed children [51]. However, one large cohort study by Turpin et al. found no association
between FUT2 genotype and the resulting phenotype is not associated with gut microbiome
composition [52].
2.5. Introduction of Solid Foods
The next major transition point in the infant gut microbiome occurs during the weaning period, when solid foods are introduced. Solid food introduction drives a shift in the
microbiome composition away from being dominated by Bifidobacterium to being dominated by Bacteroides and Firmicutes species [53]. This change in species abundance allows
for a change away from bacterial genes used for lactate digestion, to genes better suited
to carbohydrate digestion [18]. These alterations continue until three years of age and
mediate the transition toward an adult-like gut microbiome with respect to composition
and diversity. From this point, the gut microbiome remains relatively stable with the
exception of long-term dietary changes, dysbiosis caused by disease, or antibiotic exposure.
Interestingly, the introduction of solid foods too early (before three months of age) has been
associated with changes in the infant gut microbiome composition by increasing diversity
and butyrate concentrations, and has been linked to an increased risk of childhood obesity,
immune disorders, and oxidative stress [54].
3. Environmental and Lifestyle Factors That Contribute to Gut Dysbiosis
3.1. Delivery Method
The particular species initially colonising the gut microbiome of newborn babies is
greatly affected by mode of delivery (caesarean delivery or vaginal delivery), and is one of
the most important determinants for newborn gut microbiome development [55]. Studies
have found that caesarean deliveries can negatively impact the infant gut microbiome and
subsequently immune system development by altering the type and reducing the diversity
of initial colonising microorganisms. Immune and allergic disease risk are also higher in
caesarean born infants, in particular asthma, arthritis, inflammatory bowel disease, and
immune deficiencies [56]. This could be a result of caesarean deliveries contributing to gut
dysbiosis. Some strategies have been investigated to repair the newborn gut microbiota
following caesarean deliveries, such as vaginal seeding which have begun to be introduced
in certain hospitals [57]. An infant is first introduced to a wide variety of microorganisms
during delivery, where the infant is exposed to a few specific types of bacteria that colonise
the mother’s birth canal. In some cases, a caesarean delivery may be necessary, and the
infant is exposed to different set of microorganisms.
The World Health Organisation (WHO) recommends that caesarean deliveries remain
at a rate under 15%. However, in developed countries, the rate of caesarean deliveries
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has been increasing. Data from 150 countries has shown increasing rates of caesarean
deliveries from 6.7% to 19.1% from 1990 to 2014 [58]. Vaginal birth is associated with a gut
microbiome signature in newborns, as measured from early stool samples, that is similar
to the maternal vaginal microbiota, and caesarean births are associated with species that
more closely resemble skin taxa [59]. In the first week after birth, caesarean born babies
tend to have decreased levels of Bacteroides, Lactobacillus, and Bifidobacterium, and increased
amounts microorganisms associated with skin microbiomes, such as Staphylococcus, Streptococcus, and Propionibacterium [60]. After the first week of life, caesarean born infants have
reduced Bifidobacterium, and higher levels of Klebsiella, Haemophilus, and Veillonella [61].
After the first month of life, differences between the delivery methods no longer appear
significant, but with some differences in Lactobacillus, Bacteroides, and Bifidobacterium still
being detectable [62]. By 6 months of age, the colonisation patterns are near identical between vaginal and caesarean born babies. However, Bacteroides and Parabacteroides remain
higher in vaginally born infants, and Clostridium species’ are more abundant in caesarean
born infants [55].
Caesarean births often mean infants have delayed contact with their mothers, a
delayed start to breastfeeding, and the sterile environment of the operating room can
promote colonisation of hospital flora, which has been associated with a higher risk of
developing respiratory disorders [63]. In many hospitals, it is also routine to administer
(via a drip) antibiotics to the mother during delivery, leading to early infant exposure
to antibiotics during birth. One pilot study by Imoto et al. in 2018 found that maternal
antimicrobial use during delivery had a stronger impact on the newborn gut microbiome
than delivery mode, specifically reduced colonisation of Bifidobacteria [64].
Interestingly, there is a difference between elective caesareans and emergency caesareans in terms of infant gut microbiome signatures. In fact, the gut microbiome signatures
between caesareans that were preceded by the beginning of labour are more closely related
to that of vaginal births than elective caesareans. In an elective surgery, infants are not
exposed to the intrauterine inflammatory cytokines promoted by the immune response
of labour. These cytokines have been linked to stimulating the infant’s immune system
development [65].
3.2. Antibiotic Use
Antibiotics are one of the most prescribed medications and have numerous benefits.
However, their use has also been linked to both short-term and long-term negative impacts on health, such as an increased risk of autoimmune diseases and asthma [66,67].
Infants, and particularly preterm infants, are more susceptible to bacterial infections and
sepsis than adults. Antibiotic administration in early life results in decreased diversity
and changes to the abundance of particular microbial species in the gut, specifically Bifidobacterium, decreased resistance to opportunistic pathogens and increased antibiotic
resistance [68]. The disruption of the natural assembly and reduced diversity of the gut
bacteria caused by antibiotics could potentially be linked to the adverse health outcomes.
Clostridium difficile is one of the most common infections across all age groups following
antibiotic use, representing 15–25% of antibiotic associated diarrhoea and the majority of
antibiotic associated-colitis cases [69]. A systematic review conducted by Zimmermann
and Curtis investigated the effect of systemic antibiotics on the intestinal microbiome in
humans. They found that antibiotics have a profound and often persisting effect on the
gut microbiome [70]. One study performed in adults by Hagan et al. found that alterations in the gut microbiome driven by antibiotics adversely affected the responsiveness
to the influenza vaccination in humans [71]. They found that antibiotic use significantly
altered the transcriptional and metabolic processes of peripheral blood mononuclear cells
(PBMCs) [71]. It is still unclear on whether the effects of antibiotics on the gut microbiome
persist long-term, and what the extent of the effects may be. However, the specific effects on
the gut microbiome depends on the antibiotic class, route of administration, dose, duration,
and spectrum of activity (broad or narrow) [70]. When the gut microbiome is exposed to an-
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tibiotics, the microorganisms respond by harbouring and exchanging antibiotic resistance
genes (as the resistome). A paper by Palleja et al. used shotgun metagenomics to analyse
the reduction and regrowth of the adult gut microbiome over six months, after a course
of last-resort antibiotics [72]. They found that immediately following antibiotics, there
was an initial increase in Enterobacteria and other pathogenic species such as Enterococcus
faecalis, and Fusobacterium nucleatum, and a reduction in Bifidobacterium species and butyrate
producers [72]. Within one and a half months of the intervention, the gut microbiomes of
the participants recovered to almost baseline. However, there were nine species present
in all participants before the treatment that were no longer present after six months [72].
This suggests that the gut microbiome in healthy adults is resilient to the long-term effects
of antibiotics, but there may be some lasting effects, particularly in long-term antibiotic
exposure. A recent longitudinal study by Korpela et al. analysed stool samples from
infants following a course of antibiotics [73]. They found that following a single course of
antibiotics, infant gut microbiomes had varied abundances of Bifidobacteria, Enterobacteria,
and Clostridia, which persisted for several months, with Bifidobacteria levels having the most
significant variation [73]. A recent study by Sun et al. found that mice treated with antibiotics had up-regulated gene expression of various cytokines in the colon [74]. This suggests
that antibiotic-induced changes in the gut might contribute to inflammation responses.
Gaining an understanding on the role antibiotics play in affecting the composition of
the gut microbiome will help to minimise the damage caused by antibiotic treatment by
tailoring antibiotic treatment and probiotic use, which is already underway in adults. Currently, sequencing data can determine taxa within the gut microbiome but more advanced
sequencing techniques are required to provide analysis on antibiotic resistance genes in the
gut microbiome to better inform antibiotic therapies, particularly in early life, when the
gut microbiome is more susceptible to the effects of antibiotics.
3.3. Other Factors
There have been several observational studies demonstrating that exposure to pets or
siblings early in life can protect against allergic disease [75–77]. This is often coupled with
the “hygiene hypothesis”, which postulates that limiting exposure to varied microorganisms can be sub-optimal for immune development in early life. Contact with household
pets and siblings is thought to promote a more diverse gut microbiome in young children,
which is known to protect against atopy [76]. One study by Tun et al. found that infants
exposed to pets both prenatally and postnatally had a higher abundance of Ruminococcus,
and Oscillopria (studied in both caesarean and vaginal deliveries), which are negatively
associated with childhood obesity and atopy [78]. Thus, the body of evidence based upon
the effects of household furry pets on the infant gut microbiome is contentious. However,
these studies support the notion that the infant gut microbiome is highly plastic.
In recent decades, mortality rates of very preterm infants have been substantially
reduced. However, these reduced mortality rates do not correlate with reduced morbidities.
Preterm infants have an altered gut microbiome and, when paired with their immature
immune response, trigger pro-inflammatory and counter-inflammatory responses [79].
Preterm infants tend to have delayed Bifidobacterium colonisation, and a higher abundance
of Staphylococus, and Enterobacteriaceae [80]. Preterm neonates also have a tendency toward
pro-inflammatory responses, which has been associated with higher levels of Enterobacter,
Enterococcus, and Lactobacillus [81]. One study found that extremely preterm neonates
(born before 28 weeks of age) had higher levels of Lactobacillus in the infant’s meconium,
which dominates the maternal vaginal microbiome than very preterm neonates (born after
28 weeks of age); this was independent of mode of delivery [82]. This supports the notion
that the initial seeding of the GI tract is influenced by the maternal microbiome. Preterm
infants are also more likely to be hospitalised in intensive care units, and have different
nutritional requirements, which exposes the infant to the sterile hospital environment
and, in some cases, antibiotics [83,84]. Preterm infants who were born at a very-low-birthweight (VLBW) are more likely to develop intestinal microbial dysbiosis with a low gut
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microbiome diversity, reduced levels of beneficial microorganisms, and increased levels
of opportunistic pathogens [85]. This has been theorised to be caused by the interrupted
intrauterine development and may be linked to increased inflammation of the gut. VLBW
infants are also often separated from their mothers and placed in incubators to aid in body
temperature regulation.
4. Links between Gut Dysbiosis and Disease
4.1. GIT-Related Disorders
If there are disruptions in the microbial composition of the gut, the homeostatic
balance can be interrupted. This could lead to an imbalance between beneficial and
potentially pathogenic bacteria (i.e., dysbiosis). In general, dysbiosis is characterized
into different types such as a loss of beneficial microorganisms, an over production of
pathogenic microorganisms, or a loss of overall diversity in the gut. These different types
of gut dysbiosis may occur individually or all at the same time. Gut dysbiosis has been
attributed to a wide range of diseases such as IBD, obesity, allergic disorders, Type 1
diabetes, and autism [86]. The most prevalent forms of IBD are Crohn’s disease (CD) and
ulcerative colitis (UC), which are both characterized by chronic relapsing inflammation
of the intestinal mucosa, and different gut microbiome signatures [87]. Although the
specific causes of CD and UC are largely unknown, increasing evidence has linked gut
dysbiosis to IBD [88]. Patients presenting with IBD typically have overall decreased gut
microbiome diversity and stability, as well as decreased abundance of specific Firmicutes,
and an increase in Bacteroidetes, and Enterobacteriaceae [89]. There is still an unresolved
argument if intestinal dysbiosis is a direct cause for inflammation in IBD, or a result of
the disrupted GIT. As well as IBD, the gut microbiome has been linked to obesity, type 2
diabetes, colorectal cancer, and irritable bowel syndrome (IBS). In IBS, colorectal cancer,
and coeliac disease, changes in gut microbiome composition have been described when
compared to healthy controls [90]. However, there have not been any consistent patterns of
microbial change observed in the literature.
4.2. Central Nervous System-Related Disorders
Gut dysbiosis has also been linked to extra-intestinal diseases, especially those that
are affected by the gut-brain-axis, impacting the central nervous system (CNS). The gutbrain-axis is the bidirectional communication between the nervous system and the gut
microbiome. Recent research has found that the dysbiosis of the gut microbiome can alter
the development and regulation of the hypolalamic-pituitary-adrenal (HPA) axis, which
functions as a physiological adaptive response to psychological stressors [91]. In infants,
colonisation is important for the development of the enteric nervous system and the development and function of the CNS [92]. A study by Bravo et al. found that long-term
treatment with probiotics decreased levels of stress-induced corticosteroids, symptoms of
depression and anxiety [93]. Gut microbiota also play an important role in fermenting carbohydrates and proteins to produce metabolites such as SCFAs, which regulate microglial
homeostasis [94]. Primarily consisting of acetate, propionate, and butyrate, SCFAs can enter
systemic circulation, as well as other tissues and organs [95]. They may then be able to cross
the blood-brain-barrier into the central nervous system (Figure 2). Evidence supporting
this notion is lacking in human studies. However, animal studies have provided evidence
on the effect SCFAs have in CNS disorders and psychological functioning [96]. Animals
with no microbial colonisation (germ-free), or with a removed microbiome (antibiotictreated) have different neurophysiology and behavior when compared to mice with typical
colonisation patterns. Only some of these phenotypes can be restored postnatally. This
suggests a role of the maternal gestational microbiome in the development of nervous
system of their offspring [97]. Recent research has begun investigating feacal microbiota
transplantation as a strategy to alleviate gut microbiome changes associated with disorders
such as Alzheimer’s disease [98].
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The exact causes of autism spectrum disorder (ASD) are still largely unknown. However, the gut microbiome has been proposed to play a role in autism development. Children diagnosed with ASD have been found to have dysbiotic gut microbiomes and altered
SCFA levels [99–102]. One study found that mice treated with Lactobascillus rhamnosus
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showed reduced anxiety and depression symptoms, which was not observed in mice with
a vagus nerve ablation, suggesting a role of the vagus nerve in the gut-brain-axis [93]
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ance. Ling et al. found that infants who develop food allergies had distinct gut microbiome
bacterial diversity, and a low abundance of Bifidobacterium and Bacteroides, as well as an
increased abundance of Enterobacteiaceae [104]. Fujimura et al. also reported that reduced
abundance of Bifidobacterium coincided with infants that were at higher risk of atopic
dermatitis and asthma, as well as high abundances of some fungi such as Candida and
Rhodotorula, and high levels of pro-inflammatory metabolites [105]. Food allergies are
characterized by inflammation of the skin or GIT in response to particular foods and
are thought to impair oral tolerance. Ling et al. found that infants who develop food
allergies had distinct gut microbiome signatures at one year of age, with low abundances of
Bacteroides [106]. Contradictory results were found by Azad et al. who investigated infants
with food sensitivities compared to infants without, and found they had low diversities
and high abundances of Enterobacteriaceae at three months of age, and high abundances
of Bacteroides at one year of age [107]. Infants who have early dysbiotic colonisation of
Escherichia coli are also at an increased risk of developing eczema [108], and Clostridium
difficile colonisation in the first month of life is highly correlated with asthma at six to seven
years of age [109].
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5. Conclusions
There is a need for future research and a better understanding on the role gut dysbiosis
plays in inflammatory disease to inform potential mitigation strategies. This research
could lead to insights on ideal gut microbiome signatures, and will inform interventions
(for example, supplementation with pre- and pro-biotics, dietary interventions, or feacal
microbiota transplantations in more severe gut dysbiosis cases).
Numerous environmental factors culminate to influence overall patterns of microbial
colonisation of the GIT in early life. Environmental influences including delivery mode,
infant feeding patterns and methods, dietary patterns, antibiotic use, and exposure to
pets and siblings may influence overall composition and diversity. Studies continue to
investigate other factors in the built environment such as tap water quality, exposure to
green space, and their role in shaping gut microbiome development. With the availability
of next-generation sequencing technology, it is anticipated that many new discoveries will
shed new light on the ontogeny of the gut microbiome and its role in health and disease.
Author Contributions: Writing—original draft preparation, K.P.; writing—review and editing, C.T.C.,
V.V., M.N.C. and D.M. All authors have read and agreed to the published version of the manuscript.
Funding: K.P. and D.M. research funded by National Health and Medical Research Council. V.V.
research is supported by the Larsson Rosenquist Foundation.
Conflicts of Interest: The authors declare no conflict of interest.

References
1.
2.
3.
4.
5.
6.
7.
8.
9.

10.
11.
12.

13.
14.

15.
16.
17.

Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A
human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65. [CrossRef]
Hooper, L.V.; Gordon, J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292, 1115–1118. [CrossRef]
Laforest-Lapointe, I.; Arrieta, M.C. Patterns of early-life gut microbial colonization during human immune development: An
ecological perspective. Front. Immunol. 2017, 8, 788. [CrossRef]
Adamek, K.; Skonieczna-Zydecka, K.; Wegrzyn, D.; Loniewska, B. Prenatal and early childhood development of gut microbiota.
Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 9667–9680. [CrossRef]
Wang, J.Z.; Du, W.T.; Xu, Y.L.; Cheng, S.Z.; Liu, Z.J. Gut microbiome-based medical methodologies for early-stage disease
prevention. Microb. Pathog. 2017, 105, 122–130. [CrossRef]
Tang, M.L.; Mullins, R.J. Food allergy: Is prevalence increasing? Intern. Med. J. 2017, 47, 256–261. [CrossRef]
Dharmage, S.C.; Perret, J.L.; Custovic, A. Epidemiology of asthma in children and adults. Front. Pediatr. 2019, 7, 246. [CrossRef]
Fang, X.; Henao-Mejia, J.; Henrickson, S.E. Obesity and immune status in children. Curr. Opin. Pediatr. 2020, 32, 805–815.
[CrossRef] [PubMed]
Cook, M.; Douglass, J.; Mallon, D.; Smith, J.; Wong, M.; Mullins, R. Economic impact of allergies. Access Econ. 2007. Available
online: https://www.allergy.org.au/images/stories/pospapers/2007_economic_impact_allergies_report_13nov.pdf. (accessed
on 25 September 2021).
Renz, H.; Skevaki, C. Early life microbial exposures and allergy risks: Opportunities for prevention. Nat. Rev. Immunol. 2021, 21,
177–191. [CrossRef] [PubMed]
Lambrecht, B.N.; Hammad, H. The immunology of the allergy epidemic and the hygiene hypothesis. Nat. Immunol. 2017, 18,
1076–1083. [CrossRef] [PubMed]
De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of
diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci.
USA 2010, 107, 14691–14696. [CrossRef] [PubMed]
Spor, A.; Koren, O.; Ley, R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev.
Microbiol. 2011, 9, 279–290. [CrossRef] [PubMed]
Rodríguez, J.M.; Murphy, K.; Stanton, C.; Ross, R.P.; Kober, O.I.; Juge, N.; Avershina, E.; Rudi, K.; Narbad, A.; Jenmalm, M.C.;
et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 2015, 26,
26050. [CrossRef]
Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano,
R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227. [CrossRef]
Perez-Munoz, M.E.; Arrieta, M.C.; Ramer-Tait, A.E.; Walter, J. A critical assessment of the “sterile womb” and “in utero
colonization” hypotheses: Implications for research on the pioneer infant microbiome. Microbiome 2017, 5, 48. [CrossRef]
Mishra, A.; Lai, G.C.; Yao, L.J.; Aung, T.T.; Shental, N.; Rotter-Maskowitz, A.; Shepherdson, E.; Singh, G.S.N.; Pai, R.; Shanti, A.;
et al. Microbial exposure during early human development primes fetal immune cells. Cell 2021, 184, 3394–3409.e3320. [CrossRef]

Microorganisms 2021, 9, 2066

18.
19.
20.
21.

22.
23.
24.

25.
26.
27.
28.

29.

30.
31.
32.

33.
34.
35.

36.
37.

38.
39.
40.

41.

42.

11 of 14

Tanaka, M.; Nakayama, J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol. Int. 2017,
66, 515–522. [CrossRef]
Aagaard, K.; Ma, J.; Antony, K.M.; Ganu, R.; Petrosino, J.; Versalovic, J. The placenta harbors a unique microbiome. Sci. Transl.
Med. 2014, 6, 237ra265. [CrossRef]
Rautava, S.; Collado, M.C.; Salminen, S.; Isolauri, E. Probiotics modulate host-microbe interaction in the placenta and fetal gut: A
randomized, double-blind, placebo-controlled trial. Neonatology 2012, 102, 178–184. [CrossRef]
Jimenez, E.; Fernandez, L.; Marin, M.L.; Martin, R.; Odriozola, J.M.; Nueno-Palop, C.; Narbad, A.; Olivares, M.; Xaus, J.;
Rodriguez, J.M. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr.
Microbiol. 2005, 51, 270–274. [CrossRef]
Jimenez, E.; Marin, M.L.; Martin, R.; Odriozola, J.M.; Olivares, M.; Xaus, J.; Fernandez, L.; Rodriguez, J.M. Is meconium from
healthy newborns actually sterile? Res. Microbiol. 2008, 159, 187–193. [CrossRef]
Houghteling, P.D.; Walker, W.A. Why is initial bacterial colonization of the intestine important to infants’ and children’s health? J.
Pediatr. Gastroenterol. Nutr. 2015, 60, 294–307. [CrossRef] [PubMed]
Dogra, S.; Sakwinska, O.; Soh, S.E.; Ngom-Bru, C.; Bruck, W.M.; Berger, B.; Brussow, H.; Karnani, N.; Lee, Y.S.; Yap, F.; et al.
Rate of establishing the gut microbiota in infancy has consequences for future health. Gut Microbes 2015, 6, 321–325. [CrossRef]
[PubMed]
Backhed, F.; Roswall, J.; Peng, Y.; Feng, Q.; Jia, H.; Kovatcheva-Datchary, P.; Li, Y.; Xia, Y.; Xie, H.; Zhong, H.; et al. Dynamics and
stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015, 17, 852. [CrossRef] [PubMed]
Almgren, M. Benefits of skin-to-skin contact during the neonatal period: Governed by epigenetic mechanisms? Genes Dis. 2018, 5,
24–26. [CrossRef] [PubMed]
van den Elsen, L.W.J.; Garssen, J.; Burcelin, R.; Verhasselt, V. Shaping the gut microbiota by breastfeeding: The gateway to allergy
prevention? Front. Pediatr. 2019, 7, 47. [CrossRef] [PubMed]
Sela, D.A.; Chapman, J.; Adeuya, A.; Kim, J.H.; Chen, F.; Whitehead, T.R.; Lapidus, A.; Rokhsar, D.S.; Lebrilla, C.B.; German, J.B.;
et al. The genome sequence of Bifidobacterium longum reveals adaptations for milk utilization within the infant microbiome.
Proc. Natl. Acad. Sci. USA 2008, 105, 18964. [CrossRef]
Bergström, A.; Skov, T.H.; Bahl, M.I.; Roager, H.M.; Christensen, L.B.; Ejlerskov, K.T.; Mølgaard, C.; Michaelsen, K.F.; Licht, T.R.
Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants.
Appl. Environ. Microbiol. 2014, 80, 2889–2900. [CrossRef] [PubMed]
Faith, J.J.; Guruge, J.L.; Charbonneau, M.; Subramanian, S.; Seedorf, H.; Goodman, A.L.; Clemente, J.C.; Knight, R.; Heath, A.C.;
Leibel, R.L.; et al. The long-term stability of the human gut microbiota. Science 2013, 341, 1237439. [CrossRef]
Rajilić-Stojanović, M.; Heilig, H.G.; Tims, S.; Zoetendal, E.G.; de Vos, W.M. Long-term monitoring of the human intestinal
microbiota composition. Environ. Microbiol. 2012. [CrossRef]
Yassour, M.; Vatanen, T.; Siljander, H.; Hämäläinen, A.M.; Härkönen, T.; Ryhänen, S.J.; Franzosa, E.A.; Vlamakis, H.; Huttenhower,
C.; Gevers, D.; et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity
and stability. Sci. Transl. Med. 2016, 8, 343ra381. [CrossRef]
Koenig, J.E.; Spor, A.; Scalfone, N.; Fricker, A.D.; Stombaugh, J.; Knight, R.; Angenent, L.T.; Ley, R.E. Succession of microbial
consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA 2011, 108 (Suppl. S1), 4578–4585. [CrossRef]
Derrien, M.; Alvarez, A.-S.; de Vos, W.M. The gut microbiota in the first decade of life. Trends Microbiol. 2019, 27, 997–1010.
[CrossRef] [PubMed]
Zhong, H.; Penders, J.; Shi, Z.; Ren, H.; Cai, K.; Fang, C.; Ding, Q.; Thijs, C.; Blaak, E.E.; Stehouwer, C.D.A.; et al. Impact of
early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome 2019, 7, 2.
[CrossRef] [PubMed]
Deering, K.E.; Devine, A.; O’Sullivan, T.A.; Lo, J.; Boyce, M.C.; Christophersen, C.T. Characterizing the Composition of the
Pediatric Gut Microbiome: A Systematic Review. Nutrients 2020, 12, 16. [CrossRef] [PubMed]
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